Nanosonics
- Short interest
- 6.68%
- −0.83 pp 30d
- as of 9 Oct 2026
- Reported shorts
- 20M
- Shares on issue
- 299.168M
Nanosonics (NAN) Short Interest
Nanosonics (ASX:NAN) had 6.68% of shares reported as short positions as of 9 Oct 2026, representing 19,985,966 shares. Nanosonics operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Nanosonics
Nanosonics is an Australian company specializing in infection control and decontamination technologies. It aims to be a global leader by providing economical and safe solutions that prevent the transmission of infections. The company focuses on research, development, and commercialization of innovative technologies in the healthcare sector.
Company profile →Nanosonics (ASX:NAN) has 6.68% of its shares on issue reported as short positions as of 9 Oct 2026, or about 19,985,966 shares. Over the past 30 days that figure has fallen 0.83 percentage points, and over 90 days it has fallen 0.25 percentage points. Its highest recorded short interest was 14.09% in April 2018. NAN is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads NAN today
- Zanger BreakoutWatchScore 8rank 1682 of 1893
- CAN SLIMWatchScore 8rank 1269 of 1549
- Minervini Trend TemplateWatchScore 8rank 1399 of 1684
- Crowded-Short BreakoutSetupScore 40rank 51 of 1448
- Quality compoundersWatchScore 40rank 230 of 1660
Prices to 15 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
NAN fundamentals
In the year to 30 Jun 2026, Nanosonics (ASX:NAN) recorded revenue of A$203.9M and net profit after tax of A$17.8M. A year earlier it recorded revenue of A$198.9M and net profit after tax of A$20.7M. Year-on-year growth: revenue +2.5% (FY), EPS −13.8% (TTM). Net margin 8.7%, return on equity 8.3% (FY). Figures are in AUD, the company's reporting currency; source: Yahoo Finance, as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest NAN news
All news- What Did Nanosonics (ASX:NAN) Win for Its CORIS System?
kalkine · 14 Oct 2026
- Update - Notification of buy-back - NAN
asx · 13 Oct 2026
- Update - Notification of buy-back - NAN
asx · 12 Oct 2026
Company details
website
address
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss NAN
Start a research thread or post the first pulse update